Sodium–hydrogen antiporter 1

Protein-coding gene in the species Homo sapiens From Wikipedia, the free encyclopedia

The sodium-hydrogen antiporter 1 (NHE-1) also known as sodium/hydrogen exchanger 1 or SLC9A1 (SoLute Carrier family 9A1) is an isoform of sodium–hydrogen antiporter that in humans is encoded by the SLC9A1 gene.[5]

PDBOrtholog search: PDBe RCSB
AliasesSLC9A1, APNH, NHE-1, NHE1, PPP1R143, LIKNS, Sodium–hydrogen antiporter 1, solute carrier family 9 member A1
Quick facts SLC9A1, Available structures ...
SLC9A1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesSLC9A1, APNH, NHE-1, NHE1, PPP1R143, LIKNS, Sodium–hydrogen antiporter 1, solute carrier family 9 member A1
External IDsOMIM: 107310; MGI: 102462; HomoloGene: 20660; GeneCards: SLC9A1; OMA:SLC9A1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_003047

NM_016981
NM_001358455

RefSeq (protein)

NP_003038

NP_058677
NP_001345384

Location (UCSC)Chr 1: 27.1 – 27.17 MbChr 4: 133.1 – 133.15 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Close

Function

The Na+/H+ antiporter (SLC9A1) is a ubiquitous membrane-bound enzyme involved in volume- and pH-regulation of vertebrate cells. It is inhibited by the non-specific diuretic drug amiloride and activated by a variety of signals including growth factors, mitogens, neurotransmitters, tumor promoters, and others.[6]

Interactions

Sodium–hydrogen antiporter 1 has been shown to interact with carbonic anhydrase II[7] and CHP.[8][9][10] It is also the target of the experimental drug rimeporide, which is being developed for the treatment of Duchenne muscular dystrophy.[11]

References

Further reading

Related Articles

Wikiwand AI